Katherine Eberly

493 total citations · 2 hit papers
9 papers, 328 citations indexed

About

Katherine Eberly is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Katherine Eberly has authored 9 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Hepatology and 2 papers in Surgery. Recurrent topics in Katherine Eberly's work include Liver Disease Diagnosis and Treatment (9 papers), Liver Disease and Transplantation (6 papers) and Pancreatitis Pathology and Treatment (2 papers). Katherine Eberly is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Liver Disease and Transplantation (6 papers) and Pancreatitis Pathology and Treatment (2 papers). Katherine Eberly collaborates with scholars based in United States, Saudi Arabia and Philippines. Katherine Eberly's co-authors include Zobair M. Younossi, Linda Henry, James M. Paik, Khaled W. Kabbara, Youssef Younossi, Saleh A. Alqahtani, Pegah Golabi, Leyla de Avila, Reem Q. Al Shabeeb and Veronica Nguyen and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Katherine Eberly

8 papers receiving 323 citations

Hit Papers

Global burden of NAFLD and chronic liver disease among ad... 2021 2026 2022 2024 2021 2023 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Global burden of NAFLD and chronic liver disease among adolescents and young adults
    2021 153 citations James M. Paik, Khaled W. Kabbara et al. Hepatology profile →
  2. The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction–associated steatotic liver disease and alcohol-associated liver disease
    2023 71 citations Zobair M. Younossi, Maria Stepanova et al. Hepatology Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine Eberly United States 5 275 139 104 55 43 9 328
Grace En Hui Lim Singapore 7 296 1.1× 142 1.0× 112 1.1× 35 0.6× 57 1.3× 9 359
Anjali Deshpande India 4 265 1.0× 105 0.8× 158 1.5× 45 0.8× 63 1.5× 13 327
Jesús Rivera‐Esteban Spain 9 240 0.9× 106 0.8× 107 1.0× 49 0.9× 50 1.2× 28 278
Benjamin Nah Singapore 11 187 0.7× 113 0.8× 67 0.6× 42 0.8× 30 0.7× 25 271
Mohammad Nasser Kabbany United States 10 334 1.2× 172 1.2× 148 1.4× 74 1.3× 30 0.7× 20 385
Jen Jung Pan United States 6 214 0.8× 107 0.8× 105 1.0× 104 1.9× 40 0.9× 6 343
Marie Boyle United Kingdom 6 311 1.1× 162 1.2× 121 1.2× 35 0.6× 102 2.4× 10 347
KeeSeok Lee United States 5 183 0.7× 81 0.6× 78 0.8× 35 0.6× 32 0.7× 14 228
Praveen Kumar Conjeevaram Selvakumar United States 9 325 1.2× 170 1.2× 142 1.4× 94 1.7× 28 0.7× 30 401
Kristina Önnerhag Sweden 9 313 1.1× 132 0.9× 154 1.5× 46 0.8× 105 2.4× 14 373

Countries citing papers authored by Katherine Eberly

Since Specialization
Citations

This map shows the geographic impact of Katherine Eberly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Eberly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Eberly more than expected).

Fields of papers citing papers by Katherine Eberly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Eberly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Eberly. The network helps show where Katherine Eberly may publish in the future.

Co-authorship network of co-authors of Katherine Eberly

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Eberly. A scholar is included among the top collaborators of Katherine Eberly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Eberly. Katherine Eberly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Henry, Linda, et al.. (2023). Noninvasive Tests Used in Risk Stratification of Patients with Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease. 27(2). 373–395. 9 indexed citations
3.
Paik, James M., Katherine Eberly, Khaled W. Kabbara, et al.. (2023). Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.). Annals of Hepatology. 28(4). 101108–101108. 4 indexed citations
4.
Younossi, Zobair M., Maria Stepanova, Reem Q. Al Shabeeb, et al.. (2023). The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction–associated steatotic liver disease and alcohol-associated liver disease. Hepatology Communications. 8(1). 71 indexed citations breakdown →
5.
6.
Paik, James M., Patrick Austin, Katherine Eberly, et al.. (2022). Vigorous physical activity provides protection against all‐cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD). Alimentary Pharmacology & Therapeutics. 57(6). 709–722. 35 indexed citations
7.
Paik, James M., Khaled W. Kabbara, Katherine Eberly, et al.. (2021). Global burden of NAFLD and chronic liver disease among adolescents and young adults. Hepatology. 75(5). 1204–1217. 153 indexed citations breakdown →
8.
Golabi, Pegah, James M. Paik, Katherine Eberly, et al.. (2021). Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C. Annals of Hepatology. 27(1). 100556–100556. 52 indexed citations
9.
Paik, James M., Khaled W. Kabbara, Katherine Eberly, et al.. (2021). Sa350 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS DRIVING THE GLOBAL BURDEN OF CHRONIC LIVER DISEASE (CLD) AMONG ADOLESCENTS AND YOUNG ADULTS. Gastroenterology. 160(6). S–830. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Grace En Hui Lim Breakdown of academic impact, for papers by Anjali Deshpande Breakdown of academic impact, for papers by Jesús Rivera‐Esteban Breakdown of academic impact, for papers by Benjamin Nah Breakdown of academic impact, for papers by Mohammad Nasser Kabbany Breakdown of academic impact, for papers by Jen Jung Pan Breakdown of academic impact, for papers by Marie Boyle Breakdown of academic impact, for papers by KeeSeok Lee Breakdown of academic impact, for papers by Praveen Kumar Conjeevaram Selvakumar Breakdown of academic impact, for papers by Kristina Önnerhag
Rankless by CCL
2026